#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Transitional cell carcinoma Plasma cell myeloma recurrent Dupuytren's contracture Short-bowel syndrome Immunodeficiency congenital Hyperinsulinism Haemophilia A without inhibitors Usher's syndrome Neurofibroma Carcinoid tumour KBG syndrome Adrenocortical carcinoma Amyloidosis Renal disorder Cytomegalovirus infection More trials…

Learn about Rare Diseases

Hereditary hypophosphataemic rickets – Treatment Gaucher’s disease type III – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Treatment Glycogen storage disease type II – Trials in Disease Leukoencephalopathy – Basic Information Pituitary-dependent Cushing’s syndrome – Basic Information Synovial sarcoma metastatic Factor VIII deficiency – Life with Disease Stevens-Johnson syndrome – Diagnostics Piriformis syndrome – Treatment More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Sultiame Trastuzumab Emtansine Gskvx000000008866 Metformin Deupirfenidone Insulin Human (Rdna) PROMESTRIENE Methoxsalen Blu-451 Maralixibat Chloride Atacicept RO7795081 Tetrahydrouridine GS-248 Rivaroxaban [18F]-Altanserin Ganaxolone TRONTINEMAB Festuca Elatior Pollen Extract Gsk4532990A More therapies…

Learn about Your Condition

Compulsive sexual behaviour Desmoid tumour Craniopharyngioma Erectile dysfunction Intestinal obstruction Papillary thyroid cancer Giant cell arteritis Hypertrophic cardiomyopathy Benign renal neoplasm Perinatal depression Lymphatic malformation Synovial sarcoma Hyperinsulinism Ventricular fibrillation Psychological trauma More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Ovarian cancer recurrent

Study on ADP-A2M4CD8 and Nivolumab for Patients with Recurrent Ovarian Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Ovarian cancer recurrent
Investigated Drugs:
- Autologous T Cells Expressing Cd8A And A T-Cell Receptor Targeting Mage-A4
- Nivolumab
Study of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Ovarian cancer recurrent
Investigated Drugs:
+4
Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

Not recruiting

2 1 1 1
Investigated Drugs:

1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Ovarian cancer recurrent

Study on ADP-A2M4CD8 and Nivolumab for Patients with Recurrent Ovarian Cancer

Study of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer

Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies